Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling
作者:J L Oestreicher、I B Walters、T Kikuchi、P Gilleaudeau、J Surette、U Schwertschlag、A J Dorner、J G Krueger、W L Trepicchio
DOI:10.1038/sj.tpj.6500067
日期:2001.4
Psoriasis is recognized as the most common T cell-mediated inflammatory disease in humans. Genetic linkage to as many as six distinct disease loci has been established but the molecular etiology and genetics remain unknown. To begin to identify psoriasis disease-related genes and construct in vivo pathways of the inflammatory process, a genome-wide expression screen of multiple psoriasis patients was undertaken. A comprehensive list of 159 genes that define psoriasis in molecular terms was generated; numerous genes in this set mapped to six different disease-associated loci. To further interpret the functional role of this gene set in the disease process, a longitudinal pharmacogenomic study was initiated to understand how expression levels of these transcripts are altered following patient treatment with therapeutic agents that antagonize calcineurin or NF-κB pathways. Transcript levels for a subset of these 159 genes changed significantly in those patients who responded to therapy and many of the changes preceded clinical improvement. The disease-related gene map provides new insights into the pathogenesis of psoriasis, wound healing and cellular-immune reactions occurring in human skin as well as other T cell-mediated autoimmune diseases. In addition, it provides a set of candidate genes that may serve as novel therapeutic intervention points as well as surrogate and predictive markers of treatment outcome.
银屑病被认为是人类最常见的由 T 细胞介导的炎症性疾病。多达六个不同疾病基因位点的遗传联系已经确定,但分子病因学和遗传学仍然未知。为了开始确定银屑病疾病相关基因并构建炎症过程的体内通路,对多名银屑病患者进行了全基因组表达筛选。结果得出了一份包含 159 个可从分子角度定义银屑病的基因的综合列表;该列表中的许多基因都与六个不同的疾病相关基因位点相对应。为了进一步解释这组基因在疾病过程中的功能作用,我们启动了一项纵向药物基因组学研究,以了解患者在接受拮抗钙神经蛋白或 NF-κB 通路的治疗药物治疗后,这些转录物的表达水平会发生怎样的变化。在对治疗有反应的患者中,这 159 个基因子集的转录本水平发生了显著变化,而且许多变化发生在临床症状改善之前。与疾病相关的基因图谱为银屑病的发病机制、伤口愈合、人类皮肤发生的细胞免疫反应以及其他T细胞介导的自身免疫性疾病提供了新的见解。此外,它还提供了一组候选基因,可作为新的治疗干预点以及治疗结果的替代和预测标记。